glp 1 serena williams Shares Her GLP-1 Weight Loss Journey With Company Ro Serena Williams Opens Up About

The survey was performed during April and May of 2025

It is hypothesized that the slowing of gastric emptying contributes to some of the more common adverse events that occur with tirzepatide and selective GLP-1RAs (e.g., nausea, diarrhea, and vomiting), as the incidence of these events most commonly coincides with the timing of the early gastric slowing

In large cohort studies, current use of incretin-based therapy was not associated with an increased risk of hospitalization for acute pancreatitis [101] or pancreatic cancer [102]

doi: 10.1210/endocr/bqab136

We recommend patients work with their Willow physician to slowly decrease their dose in order to maintain their weight loss achievements

These ingredient-level findings do not mean NuraPatch replicates the effects seen in these studies, particularly since most research involves oral supplementation rather than transdermal patches